BEIJING, Nov. 17 (Xinhua) -- The financial burden of healthcare on patients in China has remained relatively stable in recent years amid adjustments to medical service prices and improvements in healthcare policies, the National Healthcare Security Administration (NHSA) said on Tuesday.
From 2018 to 2025, the country's overall medical service price level rose by a cumulative 26 percent, with an average annual increase of around 3.4 percent, below the average annual growth rate of per capita disposable income over the same period, according to the NHSA.
In adjusting prices, authorities have sought to balance medical institutions' operational needs, patients' ability to pay, and the financial capacity of medical insurance funds, the NHSA noted.
China has established the world's largest healthcare service system, with basic medical insurance coverage stable at roughly 95 percent of the country's 1.4 billion population.
During the 2018-2025 period, medical insurance fund spending grew by an average of 7.8 percent annually, outpacing the average annual increase in medical service prices, while the share of out-of-pocket spending in total health expenditure fell from 28.7 percent to 27.1 percent, official data revealed.
Pricing adjustments involved both increases and reductions in fees for different medical services, aiming to address structural imbalances in the pricing system in some regions, the NHSA said.
Authorities have worked to better reflect the value of medical professionals' expertise and labor in medical service pricing. For example, data showed that average fees for general outpatient consultations have risen by about 20.3 percent since 2018.
Meanwhile, prices for diagnostic tests and examinations, including PET/CT scans, have declined, according to the NHSA.
The NHSA pledged further efforts to guide local authorities in making regular, dynamic adjustments to medical service prices within an overall manageable range.
The country has continued to expand public access to healthcare services. Notably, the NHSA released an updated national medical insurance drug list last Saturday, adding 107 drugs to the catalog of medicines covered by medical insurance. ■



